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Predictive Capability of Anorectal Physiologic Tests for 
Unfavorable Outcomes Following Biofeedback Therapy  
in Dyssynergic Defecation
The purpose of this study is to evaluate the predictive capability of anorectal physiologic 
tests for unfavorable outcomes prior to the initiation of biofeedback therapy in patients 
with dyssynergic defecation. We analyzed a total of 80 consecutive patients who received 
biofeedback therapy for chronic idiopathic functional constipation with dyssynergic 
defecation. After classifying the patients into two groups (responders and non-responders), 
univariate and multivariate analyses were performed to determine the predictors associated 
with the responsiveness to biofeedback therapy. Of the 80 patients, 63 (78.7%) responded 
to biofeedback therapy and 17 (21.3%) did not. On univariate analysis, the inability to 
evacuate an intrarectal balloon (P=0.028), higher rectal volume for first, urgent, and 
maximal sensation (P=0.023, P=0.008, P=0.007, respectively), and increased anorectal angle 
during squeeze (P=0.020) were associated with poor outcomes. On multivariate analysis, 
the inability to evacuate an intrarectal balloon (P=0.018) and increased anorectal angle 
during squeeze (P=0.029) were both found to be independently associated with a lack of 
response to biofeedback therapy. Our data show that the two anorectal physiologic test 
factors are associated with poor response to biofeedback therapy for patients with 
dyssynergic defecation. These findings may assist physicians in predicting the responsiveness 
to therapy for this patient population.
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INTRODUCTION 
Dyssynergic defecation has been recognized as a major cause 
of chronic functional constipation (1). Dyssynergic defecation 
entails failure of relaxation of the puborectalis and external anal 
sphincter muscles, or their paradoxical contraction during strain-
ing to defecate, and is associated with difficult or impossible 
defecation. It was frequently termed anismus (1) or spastic pel-
vic floor syndrome, or pelvic outlet obstruction. Pelvic floor is a 
complex muscular apparatus that serves three important func-
tions: defecation, micturition, and sexual function. All-encom-
passing terms, such as ‘‘pelvic floor dyssynergia’’ or ‘‘pelvic out-
let obstruction’’ , imply that this problem affects most of the pel-
vic floor, and possibly all of its functions. Most constipated pa-
tients do not report sexual or urinary symptoms. Hence, these 
terms are not suitable. A consensus report from an internation-
al group of experts has recommended that the term ‘‘dyssyner-
gic defecation’’ most aptly describes this form of constipation; 
we also used it in this study (2, 3). 
  Biofeedback therapy is considered an effective treatment for 
chronic constipation, particularly in patients with dyssynergic 
defecation compared to those with slow transit time, and is wide-
ly employed (4). Since Bleijenberg and Kuijpers first described 
the use of biofeedback therapy to treat dyssynergic defecation 
in 1987 (5), many other authors have reported improvements of 
dyssynergic defecation following therapy in their patients (6). 
Despite these encouraging reports, a significant proportion of 
patients with dyssynergic defecation still fail to respond. To date, 
there have been only a few reports regarding those clinical fac-
tors that may predict unfavorable outcomes. Several factors, such 
as a long history of constipation (7), anal canal hypertonia (8), 
and a long anal canal with increased rectal maximum tolerable 
volume (9), are known to be associated with poor response to 
biofeedback therapy; however, no current consensus exists and 
more studies are needed to clarify these risk factors for unfavor-
able outcomes. Accordingly, the aim of this study is to evaluate 
the predictive capability of the balloon expulsion test, anorectal 
manometry, and defecogram for unfavorable outcomes in bio-
feedback prior to the initiation of therapy in patients with dys-
synergic defecation.Shin JK, et al.  •  Biofeedback in Dyssynergic Defecation
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MATERIALS AND METHODS
Participants 
Among 180 consecutive patients who underwent biofeedback 
therapy at Yonsei University Hospital, Seoul, Korea between 
October 2004 and April 2009, 36 patients complained of only 
fecal incontinence and 22 complained of both dyssynergic def-
ecation and fecal incontinence. Because fecal incontinence can 
influence results of anorectal manometry, we excluded these 
patients. Fifteen patients who had only delayed colonic transit 
time or organic disease such as Hirschsprung’s disease were also 
excluded (10). The other 27 patients did not received enough 
biofeedback therapy (more than four occasions) (11). The re-
maining 80 patients with dyssynergic defecation were included 
in this study. Constipation was defined using the Rome III diag-
nostic criteria and the diagnosis of dyssynergic defecation was 
confirmed based on one or more of the following criteria: 1) 
impaired anal relaxation during straining by manometric eval-
uation (1, 12), 2) no increase in anorectal angle during defeca-
tion, and 3) incomplete evacuation of barium on defecogram 
(10, 13, 14). 
All patients were evaluated by history, physical, and laboratory 
studies to exclude secondary causes of constipation, including 
hypothyroidism, rheumatologic disorders, or drug side effects. 
This study was approved by the Institutional Review Board of 
Severance Hospital (2-2009-0348).
Balloon expulsion test
A 3.5 cm latex balloon filled with 50 mL of warm water was in-
serted into the lower rectum through 3 mm-diameter tubing 
attached to the balloon. The patient was asked to attempt to ex-
pel the balloon in the left lateral decubitus position or into a toi-
let. Inability to evacuate the intrarectal balloon was defined as 
an attempt with expulsion failure for five minutes.
Anorectal Manometry
Anorectal manometry was performed using a standard low-com-
pliance water perfusion system (0.1 mL/min perfusion rate; Mui 
Scientific, Missisauga, Ontrario, Canada) and an eight-channel 
catheter (Zinetics Manometric Catheter, Medtronic Inc., Min-
neapolis, MN, USA) with a latex balloon (Arndorfer Inc., Green-
dale, WI, USA) on its tip. The catheter (4.5 mm external diame-
ter) had four radial channels below the balloon and four spiral 
channels. The performance protocol included the stationary 
pull-through technique in 1 cm increments while recording 
anal canal length, resting anal sphincter pressure, and maximal 
squeezing pressure. Pressures were recorded using a comput-
erized recording device (POLYGRAM NET, Medtronic Inc., Min-
neapolis, MN, USA). Rectal volume was examined by balloon 
distension in the rectum. A balloon was inserted into the rectum 
and inflated in 20 mL increments, up to 250 mL, to assess the 
threshold volume for the first and urgent sensation to defecate 
as well as maximal tolerable sensation. The recto-anal inhibito-
ry reflex was also assessed to exclude Hirschsprung’s disease.
Defecogram
With the patient in the left lateral decubitus position, the rectum 
was filled with barium paste, and the patient was seated upright 
on a specially designed commode before being asked to empty 
the rectum as rapidly and completely as possible. Plain radiog-
raphy were taken under fluoroscopic control. Anorectal angles 
during rest, squeeze, and defecation were measured using the 
central axis method. Perineal descent was measured as the ver-
tical distance between the anorectal junction and the pubococ-
cygeal line. Anal diameter during defecation was also measured. 
A normal defecographic pattern was defined as rapid and com-
plete evacuation of contrast material with both increased ano-
rectal angle and normal opening of the anal canal (8).
Biofeedback therapy
Biofeedback therapy was performed using the Kontinence
TM 
Clinical HMT2000 (HMT Inc., Seoul, Korea) with anorectal elec-
tromyography (EMG) sensor and surface electrodes. The treat-
ment protocol included twice weekly sessions, lasting longer than 
40 min each, for five weeks in the outpatient clinic. A deta–iled 
description of the procedure follows. While the patient was seat-
ed on a commode, an anorectal EMG electrode was placed in the 
anus to monitor muscular activity in the external anal sphincter 
and puborectalis muscle during rest, squeezing, and relaxing. 
Surface electrodes were attached to the abdominal wall to de-
tect abdominal wall muscle contraction. The electrical activity 
of the sphincter appeared as a fluctuating light bar. Patients were 
taught to squeeze and relax their anal muscles while watching 
the EMG signals on the monitor. Episodes of bowel movements, 
satisfaction score and incomplete defecation score were evalu-
ated by a questionnaire prior to each session (15). The satisfac-
tion score was scaled from 0 (dissatisfaction) to 10 (full satisfac-
tion) (15). The incomplete defecation score was scaled from 0 
(absent incomplete defecation) to 10 (severe incomplete defe-
cation). Biofeedback therapy was considered successful, and 
patients were considered responders, if the following criteria 
were satisfied: 1) bowel frequency increased to three or more 
episodes per week (9) and 2) increase of satisfaction score of five 
or more, or 3) decrease of incomplete evacuation score of five 
or more (15). After classifying the patients into responders and 
non-responders, as assessed by subjective and objective param-
eters, univariate and multivariate analyses were performed to 
evaluate predictors associated with the responsiveness of bio-
feedback therapy. 
Statistical analysis 
Statistical analysis was performed with SPSS 12.0 (Statistical Shin JK, et al.  •  Biofeedback in Dyssynergic Defecation
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Package for the Social Sciences for Windows, Chicago, IL, USA) 
using the independent t-test for continuous variables and the 
chi-square and Fisher’s exact tests for dichotomous variables 
(univariate analysis). Logistic regression was used for multivari-
ate analysis. P values <0.05 were considered to be statistically 
significant.
 
RESULTS
Demographics and symptoms
The mean symptom duration of the 80 patients was 7.2 yr (range, 
1-25 yr) and the mean bowel movement frequency was 2.3 per 
week. No significant biofeedback related complications were 
identified. Of the 80 patients (32 male, 48 female), 63 (78.7%) 
responded to biofeedback therapy and 17 (21.3%) did not. There 
was no significant difference in demographic profiles or other 
characteristics, including symptom duration and bowel move-
ment frequency, between responders and non-responders (Ta-
ble 1).
Balloon expulsion test
Of the 39 patients who successfully expelled the balloon, four 
(10.3%) did not respond to biofeedback therapy. Of the 41 pa-
tients who failed to expel the balloon, 13 (31.7%) did not respond 
to biofeedback therapy. The inability to evacuate an intrarectal 
balloon on the balloon expulsion test was significantly related 
to failure of biofeedback therapy (P=0.028).
Anorectal manometry
The response to biofeedback therapy was not influenced by anal 
canal length, resting anal sphincter pressure, maximal squeez-
ing pressure, or recto-anal gradient during coughing (Table 1). 
Paradoxical contraction also did not influence the results of bio-
feedback therapy. However, the rectal volume for first, urgent, 
and maximal sensation was significantly higher in non-respond-
ers than responders (59.4±44.7 vs. 35.0±36.2 mL; P=0.023, 125.2 
±61.0 vs. 87.7±47.0 mL; P=0.008, 197.5±64.4 vs. 149.0±66.1 mL; 
P=0.011, respectively) (Table 2).
Defecogram
The anorectal angle during the squeeze increased in non-re-
sponders compared to responders (106.4±32.8° vs. 89.2±20.6°; 
P=0.020). The anorectal angles during rest and defecation were 
not significantly different between groups. Neither perineal de-
scent nor anal diameter during defecation were related to the 
response to biofeedback (Table 3).
Multivariate analysis
Multivariate analysis was performed for those variables signifi-
cant in univariate analysis. Inability to evacuate an intrarectal 
balloon (odds ratio=7.51, P=0.018) and increased anorectal an-
gle during squeeze (odds ratio=1.03, P=0.029) were found to be 
the factors independently associated with failure to respond to 
biofeedback therapy.
DISCUSSION
In defining dyssynergia defecation, most published studies have 
used arbitrary or symptomatic diagnostic criteria. The recent 
criteria for dyssynergic defecation (3, 16) appears more suitable 
for selecting dyssynergic defecation patients because the pres-
ence of constipation symptoms together with dyssynergic pat-
tern of defecation and at least one additional abnormal test (e.g., 
prolonged balloon expulsion time, prolonged colonic transit, or 
excessive barium retention with defecography) shows a high 
diagnostic yield in identifying dyssynergic defecation (3, 17). 
Although most patients enrolled in our study satisfied Rome III 
criteria and demonstrated dyssynergia on manometric exami-
nation, we acknowledge that this is a retrospectively designed 
Table 1. Comparison of the clinical characteristics of responders and non-responders 
with dyssynergic defecation
Parameters
Responders           
(n=63)
Non-responders
(n=17)
P 
value
Sex (male/female) 22/41 10/7 0.074
Age (yr)  53.8±14.3 60.2±14.0 0.105
Diabetes mellitus 6/57 2/15 0.676
Symptom duration (month) 7.2±7.3 7.2±6.5 0.995
Bowel movement frequency (/week) 2.30±2.09 1.47±1.54 0.495
Initial satisfaction score (0-10)* 2.39±2.28 1.88±3.10 0.449
Incomplete evacuation score (0-10)
†  6.50±3.13 5.30±4.21 0.339
*0=dissatisfaction, 10=satisfaction; 
†0=absent, 10=severe.
Table 2. Comparison of balloon expulsion and manometric parameters between res–
ponders and non-responders with dyssynergic defecation prior to biofeedback therapy
Parameters Responder
Non- 
responder
P 
value
Balloon expulsion test (success/failure) 35/28 4/13 0.028
Anorectal manometry
   Anal canal length (cm)   4.61±0.73   4.76±0.66 0.439
   Resting anal sphincter pressure (mmHg)   59.0±37.3   55.6±25.9 0.730
   Maximal squeezing pressure (mmHg)   182.7±106.3   219.1±123.0 0.239
   Recto-anal gradient during coughing 
       (mmHg)
  63.8±75.2   80.0±53.3 0.421
   Paradoxical contraction 52/16 11/1 1.000
   Rectal volume for first sensation (mL)   35.0±36.2   59.4±44.7 0.023
   Rectal volume for urgent sensation (mL)   87.7±47.0 125.2±61.0 0.008
   Rectal volume for maximal sensation (mL)  149.0±66.1 197.5±64.4 0.011
Table 3. Comparison of defecogram parameters between responders and non-res–
ponders with dyssynergic defecation prior to biofeedback therapy
Parameters Responder Non-responder P value
Anorectal angle during rest (°) 105.5±18.7 112.6±18.6 0.205
Anorectal angle during squeeze (°)   89.2±20.6 106.4±32.8 0.020
Anorectal angle during defecation (°) 110.9±22.0 123.5±27.1 0.083
Perineal descent (cm)   24.8±17.2   14.3±13.9 0.070
Anal diameter during defecation (cm) 13.6±5.4 14.0±5.2 0.866Shin JK, et al.  •  Biofeedback in Dyssynergic Defecation
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study and our enrollment criteria correspond to the criteria used 
in many previous studies, but not the recent criteria. There were 
some patients who did not undergo a colon transit time study 
or barium evacuation study during defecogram. Moreover, the 
criteria for the balloon expulsion test was 5 min in our study like 
many other studies (4). Recently, 5 min criteria also changed to 
those with 1 min (3). These recent criteria will definitely play an 
important role in designing the next prospective study because 
they define dyssynergic defecation more properly.
  Biofeedback therapy is an effective treatment option for chron-
ic constipation. Prior to the introduction of biofeedback thera-
py, anal myectomy, subtotal colectomy, and colostomy had been 
attempted with limited success. Since Bleijenberg and Kuijpers 
(5) initially reported the resolution of symptoms in patients with 
dyssynergic defecation following biofeedback therapy, numer-
ous subsequent studies have reported good outcomes with this 
therapy (18, 19). Biofeedback therapy may be performed in the 
hospital setting (10) or in the home to reinforce the initial train-
ing for an extended period (6). We performed EMG-based bio-
feedback, which was reported to be more effective than other 
methods (20), in the outpatient clinic. Home therapy was not 
offered due to limited equipment availability. Instead, patients 
were instructed to perform exercises twice daily for ten minutes, 
alternating five–second squeeze and ten-second resting inter-
vals. We included 80 patients who performed biofeedback ther-
apy on more than four occasions as the success rate has been 
shown to improve significantly after five or more sessions. Ac-
cording to the study of Gililand et al. (11), only 18% of patients 
who had between two and four sessions achieved complete suc-
cess, compared to 44% of those who had five or more. 
  Many studies have reported an improvement of symptoms, 
including degree of straining, bowel satisfaction and effective 
straining following biofeedback therapy, and have considered 
these to be criteria for success. Recently, there have been ran-
domized prospective trials about biofeedback therapy in consti-
pation. Chiarioni et al. (21) used the degree of global improve-
ment of symptom as a response criteria (primary outcome) and 
classified it into five grades (worse, no improvement, mild, fair, 
and major improvement). Heymen et al. (22) asked patients 
whether they had experienced adequate relief of constipation 
and used it as a primary outcome. Rao et al. (23) included not 
only the grade of global satisfaction, but also the number of com-
plete spontaneous bowel movements, balloon expulsion time, 
and presence of dyssynergia measured by physiologic tests in 
primary response criteria. In these recent studies, one of the main 
response criteria of biofeedback was global symptom improve-
ment which was measured in different scales. Considering that 
constipation is a symptom–based disorder, these criteria appear 
reasonable and we also included the degree of symptom imp–
rovements (satisfaction score and incomplete defecation score) 
in our main response criteria for dyssynergic defecation. How-
ever, only symptom-based criteria are entirely dependent on 
patients’ subjective measurements and may therefore be arbi-
trary. Thus, many previous studies have compared bowel fre-
quencies before and after treatment (14) and considered a bow-
el frequency increase up to three or more episodes per week as 
an objective criterion (9). Accordingly, in the present study, bio-
feedback therapy was considered successful (responders) if both 
subjective (satisfaction score or incomplete evacuation score) 
and objective parameters (bowel frequency ≥3/week) were sat-
isfied like other studies. 
  In the current study, there were no significant differences be-
tween responders and non-responders in demographic or clin-
ical characteristics. The results showed that the inability to evac-
uate an intrarectal balloon on the balloon expulsion test was 
related to the failure of biofeedback therapy. Several previously 
published studies using various expulsion tests have also dem-
onstrated that impaired expulsion capacity is related to poor 
treatment outcomes (24, 25). The reason for these results is un-
clear; however, because the severity of defecatory dysfunction 
was evaluated by means of the balloon expulsion test (25), we 
speculate that severe defecatory dysfunction prior to biofeed-
back therapy is related to treatment failure. According to Mckee 
et al. (26), biofeedback was not helpful in patients who had de-
ranged pelvic floor physiology. These patients probably sustain–
ed neurological damage to the pelvic floor during childbirth. 
Snooks et al. (27) described the separate innervations of the pu-
borectalis and external sphincter, and suggested that damage to 
more than one innervations in some constipated patients may 
occur rather than pudendal neuropathy alone. This study indi-
cates that differential damages to the nerves and muscles of the 
pelvic floor can occur, leading to problems with defecation due 
to disordered pelvic floor contraction in some individuals. If this 
damage is severe, it may not be possible to improve the situation 
with biofeedback training. It also seems to be logical that biofeed-
back is unsuccessful in patients with severely blunted rectal sen-
sation since functioning sensory afferents are presumably re-
quired to detect rectal fullness and the need for defecation. The 
findings above are consistent with our findings that more severe 
patients responded less frequently to biofeedback therapy. In 
the current study, the results suggest that many patients who fail 
to expel the balloon are likely to be non-responders and should 
therefore be recommended more intensive biofeedback therapy 
or alternative treatments. There have also been several reports 
suggesting that the balloon expulsion test does not predict the 
responsiveness to biofeedback therapy (4, 9). The difference in 
results among studies seems to be related to heterogenous pa-
tient populations, different success criteria, and varying biofeed-
back techniques. Further studies regarding the relationship be-
tween the balloon expulsion test and biofeedback therapy are 
needed.
  Compared with previous studies suggesting that parameters Shin JK, et al.  •  Biofeedback in Dyssynergic Defecation
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of defecogram were not related to outcomes of biofeedback ther-
apy (8, 16), our study showed that the anorectal angle during-
squeeze (106.4±32.8°) significantly increased in non-respond-
ers. Normally, the anorectal angle on defecogram at rest has a 
range of 92-114° and is more obtuse during defecation (110-180°) 
and more acute during squeeze (75-90°) (28). The results sug-
gest that the anorectal angle duringsqueeze reflects the possi-
bility of improvement in the puborectalis muscle following bio-
feedback therapy.
  Rhee et al. (9) reported that anal canal length and rectal max-
imum tolerable volume were associated with poor response to 
biofeedback therapy. In that study, anal canal length was longer 
and rectal maximal tolerable volume increased in non-respond-
ers compared to responders (9). However, in the current study, 
anal canal length yielded no predictive value. The rectal maxi-
mal tolerable volume, as well as rectal volume for first and ur-
gent sensation, was significant upon univariate analysis, but did 
not remain so upon multivariate analysis. The term rectal hypo-
sensitivity, defined as the elevation of sensory thresholds beyond 
the normal range, relates to impaired or blunted rectal sensory 
function. Although the mechanism for the development of con-
stipation in patients with rectal hyposensitivity is not entirely 
clear, it has been classified as one of the principal physiologic 
abnormalities in patients with functional constipation (29). Jung 
et al. (30) reported that patients with a more hyposensitive rec-
tum showed non-response to biofeedback more frequently, sug-
gesting rectal hyposensitivity was an important factor in biofeed-
back therapy responsiveness. Our results also showed the rectal 
volumes were higher in non-responders upon univariate analy-
sis and further studies regarding the relationship between rec-
tal hyposensitivity and biofeedback therapy are needed.
  It has previously been reported that a long duration of consti-
pation (7) and basal anal hypertonia (8) are associated with a poor 
response to biofeedback therapy in constipated patients. How-
ever, there were no significant differences between responders 
and non-responders in the current study and several reports are 
in agreement with our findings (15, 25).
  The present study has several limitations. First, it was a retro-
spective analysis which may potentially lead to limitations due 
to the investigational design. Second, a relatively small sample 
size was included in this study. Finally, although the biofeedback 
training procedures used in this study are representative of what 
has been described in the literature, techniques and equipment 
used by some laboratories differ from ours. To overcome these 
limitations, a large-scale prospective study with a standard meth-
od and equipment is warranted.
  In conclusion, our data show that the inability to evacuate an 
intrarectal balloon and increased anorectal angle during squeeze 
are associated with poor response to biofeedback therapy for 
patients with dyssynergic defecation. These findings may assist 
physicians in predicting the responsiveness to therapy for this 
patient population.
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